InvestorsHub Logo
Followers 17
Posts 1224
Boards Moderated 1
Alias Born 06/30/2014

Re: 123414 post# 2126

Friday, 10/21/2016 10:03:01 AM

Friday, October 21, 2016 10:03:01 AM

Post# of 4159
This was the next BIG milestone.

You/we can only take these one step at a time. This was HUGE in the process.

As far as what I think as to why HC did approve much earlier than expected: There's very high credibility within the team that RW has assembled across the multiple elements linked together to get this to a Ph1-b trial. I think that lead HC to conclude that there is very little risk to the procedures based on PMCC participation, and the medical team experience and reputations that's been assembled

I do think that the pps will reflect the milestone. I don't think the "word" is out yet and we will see pps appreciation of 10%-20%. I think that's a low estimate/guess, but I try to estimate low regardless. If it goes higher I'm happy to be wrong.

I think that once the financing is done, there will be other lab rat tests to move the PDC across multiple cancers as quickly as possible. Only funding is holding back the research and testing.

The more data and research, the more exposure and pps appreciation. IMO.

Regards,
BK